Search for: "Ortho-McNeil Pharmaceuticals"
Results 141 - 160
of 270
Sort by Relevance
|
Sort by Date
22 May 2010, 10:12 pm
An affiliate of Ortho-McNeil, Janssen Pharmaceuticals, has agreed to pay $75 million to settle claims under the False Claims Act that it illegally promoted Topamax for psychiatric purposes and submitted alleged false claims to Medicare. [read post]
20 May 2010, 7:01 am
No. 5,053,407, exclusively licensed to Ortho-McNeil Pharmaceutical, is... [read post]
19 May 2010, 10:48 am
Ortho-McNeil Pharma v. [read post]
19 May 2010, 6:15 am
Lupin Pharmaceuticals, Inc. [read post]
18 May 2010, 7:03 pm
The agreement also mandates a centralized system that tracks all presentation engagements by Ortho-McNeil personnel. [read post]
16 May 2010, 9:59 pm
Noonan -- In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Levaquin (Levofloxacin) - US: CAFC upholds patent term extensions in Levaquin and Metvixia cases: Ortho-McNeil and Daiichi Sankyo v. [read post]
13 May 2010, 4:57 pm
Two subsidiaries of Johnson & Johnson, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., have agreed to pay more than $81 million to settle allegations that they violated the False Claims Act by illegally promoting the epilepsy drug, Topomax. [read post]
11 May 2010, 7:07 pm
The suit names Johnson & Johnson, Ortho-McNeil Pharmaceuticals Inc. and Johnson & Johnson Pharmaceutical Research and Development LLC as defendants to Presley's claim. [read post]
10 May 2010, 11:26 am
Three recent cases before the CAFC went to challenges to patent term extension. [read post]
10 May 2010, 10:37 am
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
3 May 2010, 11:01 am
The District Court in Boston has posted the plea agreement and criminal Information filed against Ortho-McNeil Pharmaceutical, LLC, in the settlement announced last week by the Department of Justice. [read post]
2 May 2010, 6:32 pm
The government alleged that Ortho-McNeil Pharmaceutical promoted the sale of Topamax for unapproved psychiatric uses. [read post]
30 Apr 2010, 4:07 am
Source.While the Food and Drug Administration approved Topamax for the treatment of partial onset seizures, Ortho-McNeil Pharmaceutical promoted the drug for unapproved psychiatric uses, the government said [read post]
29 Apr 2010, 1:26 pm
Ortho-McNeil Pharmaceutical, Civil Action No. 03-11445-WGY, and United States ex rel. [read post]
29 Apr 2010, 1:26 pm
Ortho-McNeil Pharmaceutical, Civil Action No. 03-11445-WGY, and United States ex rel. [read post]
29 Apr 2010, 2:06 am
The Department of Justice announced on April 29 that Ortho-McNeil Pharmaceutical, LLC, and Ortho-McNeil-Janssen Pharmaceuticals, Inc., two subsidiaries of Johnson & Johnson, have agreed to pay $81 million to settle charges brought in two whistleblower suits that they violated the False Claims Act by promoting Topamax for off-label (unapproved) uses. [read post]
23 Apr 2010, 8:20 am
., Bose, Brigham Young University, Cornell University, Stanford University, Duke University, Georgetown University, GlaxoSmithKline, Honeywell, Harvard University, Johnson & Johnson, Kauffman Foundation, Lockheed Martin, Massachusetts Institute of Technology (MIT), Mayo Clinic, Ortho-McNeil Pharmaceuticals Inc., Rutgers, Syngenta Biotechnology, Scripps Research Institute, U.S. [read post]
7 Apr 2010, 4:30 am
Reddy's Laboratories, Ltd. et al (Docket Report) Retin-A Micro (Tretinoin) – US: District Court E D Texas: Promote Innovation files false marking complaint against Ortho-McNeil based on marking of Retin-A Micro product (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: Teva receives favourable court decision regarding Seasonique (SmartBrief) (The IP Factor) T2007 (Diphenyl barbituric acid) – US: Taro receives patent for new drug T2007 (The IP… [read post]
31 Mar 2010, 1:58 pm
Pressure Products Medical Supplies invented a valve remover for an introducer, netting 5,125,904 & 5,312,355. [read post]
